Timeline: 15 years EB House Austria

2004

In autumn 2004 the ground-breaking ceremony for the construction of the EB House Austria takes place

(c) R. Hametner

2005

In November 2005 the EB House Austria is opened with three units: outpatient clinic (Dr. Anja Diem), research unit (Prof. Johann Bauer) and academy (Dr. Gabi Pohla-Gubo)

(c) R. Hametner

2005

Visit of the Federal President Heinz Fischer & Governor Gabi Burgstaller in the EB House

(c) R. Hametner

2011

Foundation of the clinical expert network EB-CLINET

2012

The first EB-CLINET conference takes place in Salzburg with 106 participants from 33 countries

(c) R. Hametner

2012

The Diacerein ointment with the active ingredient from the rhubarb root, which was developed in the EB House, is tested for the first time on 5 EBS patients

(c) R. Hametner

2012

The EB House research unit is evaluated by the FWF and external experts

(c) R. Hametner

2013

The EB Handbook, an online reference book for EB patients and a project from the EB outpatient clinic, goes online

2013

EB House researchers establish next-generation sequencing for diagnosis and research

(c) R. Hametner

2013

The second EB-CLINET conference takes place in Salzburg with 91 participants from 29 countries

(c) R. Hametner

2014

The EB House laboratory is already getting too small, so that the gene and cell therapy group moves to the newly opened 2nd EB laboratory at the PMU

(c) R. Hametner

2014

The first ex vivo gene/stem cell therapy is applied to a patient with JEB

(c) R. Hametner

2015

The application of ex vivo gene/stem cell therapy saves the life of a 7-year-old JEB patient

(c) R. Hametner

2015

Prof. Helmut Hintner retires and hands over his offices to Prof. Johann Bauer

(c) R. Hametner

2016

The effectiveness of an ointment containing Vitamin D for wound healing is being tested in a clinical study on RDEB patients

(c) R. Hametner

2017

The EB House is designated as the first center of expertise for rare genodermatoses in Austria

(c) Wildbild

2017

The EB House becomes a member in the European reference network ERN-Skin

(c) ERN-Skin

2017

Establishment of a biobank for the collection, storage and provision of laboratory samples

(c) R. Hametner

2017

The diacerein project is taken up by Castle Creek Biosciences who will pursue the clinical development of this ointment, in order to achieve marketing authorization.

(c) Castle Creek Biosciences

2017

The 4th EB-CLINET Conference and the International EB Research Conference take place as a joint congress in Salzburg with 300 participants from 36 countries

(c) R. Hametner

2017

The first large-scale ex vivo gene/stem cell therapy study is initiated (initially for RDEB patients, then in 2019 also for JEB)

(c) R. Hametner

2017

The EB House research unit is evaluated for the 2nd time by the FWF and international experts

(c) R. Hametner

2018

The EB Study Center becomes the fourth unit of the EB House (Assoc. Prof. Martin Laimer)

(c) L. Schedl

2019

Dr. Gabi Pohla-Gubo retires and hands over the management of the EB Academy to Dr. Sophie Kitzmüller

(c) R. Hametner

2019

All departments of the EB House are ISO 9001 certified

(c) SALK

2020

The EB House receives the Black Pearl Award in the category "Holistic Care"

(c) A. de Wilde

2020

The EB House turns 15 years old - a reason to celebrate!